Hyundai Bioscience Co. Ltd (048410) — Cash Flow Quality Index
Hyundai Bioscience Co. Ltd (048410) has a Cash Flow Quality Index of 5.09x as of June 2024. Operating cash flow of ₩8.02 Billion exceeds net income of ₩1.58 Billion, indicating high earnings quality where cash backs reported profits. Explore Hyundai Bioscience Co. Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hyundai Bioscience Co. Ltd Cash Flow Quality Index (2008–2019)
Historical Cash Flow Quality Index for Hyundai Bioscience Co. Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Hyundai Bioscience Co. Ltd (048410) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Hyundai Bioscience Co. Ltd (2008–2019)
Year-by-year earnings quality comparison for Hyundai Bioscience Co. Ltd. For live market cap and the full company financial profile, see Hyundai Bioscience Co. Ltd market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 11.96x | ₩9.18 Billion | ₩767.22 Million | ▲ +525.8% |
| 2018 | 1.91x | ₩5.01 Billion | ₩2.62 Billion | ▲ +163.0% |
| 2017 | -3.03x | ₩-3.70 Billion | ₩1.22 Billion | ▼ -2570.3% |
| 2015 | 0.12x | ₩87.36 Million | ₩711.29 Million | ▼ -93.8% |
| 2008 | 1.97x | ₩10.37 Billion | ₩5.26 Billion | — |